# SAREPTA THERAPEUTICS INC (SRPT)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/SRPT/

- Reporting holders: 9
- Reported value: $103.5K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $39.9K | 2,191 | 0.0% | 12 |
| [ATWOOD & PALMER INC](https://holderbook.com/funds/1044929-atwood-palmer-inc/) | $25.5K | 1,400 | 0.0% | 14 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $20.2K | 1,107 | 0.0% | 16 |
| [Versant Capital Management, Inc](https://holderbook.com/funds/1735057-versant-capital-management-inc/) | $8.7K | 478 | 0.0% | 4 |
| [CoreCap Advisors, LLC](https://holderbook.com/funds/1902501-corecap-advisors-llc/) | $5.3K | 292 | 0.0% | 8 |
| [MassMutual Private Wealth & Trust, FSB](https://holderbook.com/funds/1103653-massmutual-private-wealth-trust-fsb/) | $2.4K | 129 | 0.0% | 22 |
| [MJT & Associates Financial Advisory Group, Inc.](https://holderbook.com/funds/2065777-mjt-associates-financial-advisory-group-inc/) | $1.3K | 69 | 0.0% | 4 |
| [GILPIN WEALTH MANAGEMENT, LLC](https://holderbook.com/funds/2058144-gilpin-wealth-management-llc/) | $164 | 9 | 0.0% | 4 |
| [Davis Capital Management](https://holderbook.com/funds/1811806-davis-capital-management/) | $109 | 6 | 0.0% | 2 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 9 | $103.5K |
| Q2 2026 | 332 | $2.3B |
| Q1 2026 | 347 | $2.5B |
| Q4 2025 | 356 | $2.3B |
| Q3 2025 | 327 | $2.0B |
| Q2 2025 | 371 | $1.7B |
| Q1 2025 | 435 | $5.7B |
| Q4 2024 | 470 | $11.1B |
| Q3 2024 | 463 | $11.6B |
| Q2 2024 | 492 | $15.4B |
| Q1 2024 | 422 | $12.1B |
| Q4 2023 | 407 | $9.3B |